Phospho-Thr172 CDK4 is associated with both D-type cyclins and CDK inhibitors. (A to C) IMR-90 fibroblasts; (D to F) dog thyrocytes. (A) Western blotting analyses of CDK4, cyclin D3, cyclin D1, p21, p27, and p16 from whole-cell extracts of quiescent unstimulated IMR-90 cells (Cont) or cells stimulated by 20% serum for 16 or 24 h. p38 mitogen-activated protein kinase (MAPK) was detected as a loading control. (B) CDK4 separated by 2D gel electrophoresis was detected by Western blotting with a CDK4 antibody from (co)immunoprecipitates (IP) of cyclin D1, cyclin D3, p21, p27, or p16 from quiescent unstimulated IMR-90 cells (Cont), cells stimulated with 20% serum for 16 h (16 h), or cells stimulated for 16 h and treated for 3 h with the protein synthesis inhibitor cycloheximide (100 μg/ml) in the presence of serum (16 h + 3 h Cx). In the inset, controls of cycloheximide impact on the presence of proteins in whole-cell extracts are shown; D1-bound CDK4 and p16-bound CDK4 are CDK4 coimmunoprecipitated using cyclin D1 and p16 antibodies, respectively. (C and D) Extracts from IMR-90 cells (C) stimulated or not (Cont) by 20% serum for 16 h or dog thyrocytes (D) stimulated or not (Cont) by forskolin (Forsk) were immunoprecipitated with anti-p16, anti-cyclin D1, anti-cyclin D3, anti-p21, or anti-p27 antibodies or a control immunoglobulin (IgG), assayed for pRb kinase activity, separated by SDS-PAGE, and immunoblotted. Cyclin D3, CDK4 and its activating Thr172 phosphorylation (P-T172-CDK4), cyclin D1, p16, p21, p27, and the pRb fragment phosphorylated in vitro at Ser780 (P-Rb-780) were detected using specific antibodies. (E) Western blotting analyses of CDK4 separated by 2D gel electrophoresis from coimmunoprecipitates of p27 from quiescent unstimulated dog thyrocytes (Cont) or cells stimulated with TSH (1 mU/ml) or TSH plus EGF plus 10% serum (ETS) for 20 h. (F) Extracts from dog thyrocytes stimulated for 20 h with TSH were immunoprecipitated with p27 antibodies (p27 IP) or a phospho-specific (Ser10) p27 antibody (P-S10-p27 IP), separated by 2D gel electrophoresis, and electroblotted. Immunodetections were performed using antibodies against total p27 or p27 phosphorylated on Ser10 (P-S10-p27) or with a mixture of CDK4 and p27 antibodies. In panels B, E, and F, arrows 3 indicate the main Thr172-phosphorylated form of CDK4.